Cardiac papillary fibroelastoma: a retrospect of four cases

Mi Zhang1, Xiaohong Liu, Zhigang Song

  • 1Department of Cardiothoracic Surgery, Changhai Hospital, Second Military Medical University, No168, Changhai Road, Yangpu District, Shanghai 200433, China.

Insights

Cardiac papillary fibroelastomas, though benign, pose embolic risks. Surgical removal is recommended for all patients to prevent complications like stroke.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Oncology
  • Pathology

Background:

  • Cardiac papillary fibroelastomas are rare primary cardiac tumors.
  • These tumors, despite being histologically benign, can lead to significant embolic events.

Observation:

  • A review of 4 patients treated between 2004 and 2011 at Changhai Hospital.
  • Tumor locations included the mitral valve, left atrium, and aortic valve.
  • Indications for surgery varied, including cerebrovascular accident, mobile mass, chest tightness, and severe aortic regurgitation.

Findings:

  • All 4 patients underwent surgical excision with valve replacement where necessary.
  • Postoperative recovery was uneventful for all patients.
  • Echocardiography at follow-up showed no evidence of regurgitation or tumor recurrence.

Implications:

  • Surgical excision of cardiac papillary fibroelastomas is crucial, regardless of their benign nature.
  • Early intervention can prevent potentially devastating embolic complications.
  • This highlights the importance of prompt diagnosis and management of cardiac tumors.
Abstract